Since its formation in 2002, ZeaChem has continued to progress its biorefining technology advancing from lab based R&D through research center based pilot and on to demonstration based operations building out a portfolio of biorefining IP, physical assets, and commercial opportunities. ZeaChem has 34 published patents around its core C2 & C3 bacterial fermentation technology. ZeaChem has built and operates a multi-million dollar, 10 bone dry ton per day input, 250,000 gal per year ethanol or equivalent biochemical output, demonstration plant in Boardman, OR.